ITEM
1. FINANCIAL STATEMENTS
The
interim financial statements included herein are unaudited but reflect, in managements opinion, all adjustments, consisting only
of normal recurring adjustments that are necessary for a fair presentation of our financial position and the results of our operations
for the interim periods presented. Because of the nature of our business, the results of operations for the quarterly period and the
nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the full fiscal year.
Earth
Life Sciences Inc.
|
Balance
Sheets
|
As
at
|
(unaudited)
|
|
|
Note
|
|
September 30, 2021
|
|
|
December 31, 2020
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
Current Assets
|
|
|
|
|
|
|
|
|
|
|
Prepaid expenses
|
|
|
|
$
|
1,000
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition of software technology
|
|
|
|
|
176,000
|
|
|
|
176,000
|
|
Property and equipment - net
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
$
|
177,000
|
|
|
$
|
176,000
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
|
|
|
|
|
|
Current Liabilities
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
|
|
$
|
67,054
|
|
|
$
|
51,037
|
|
Amounts owing to related parties
|
|
|
|
|
-
|
|
|
|
665
|
|
Notes payable
|
|
|
|
|
46,903
|
|
|
|
28,603
|
|
Convertible debt
|
|
|
|
|
260,753
|
|
|
|
297,603
|
|
Total Liabilities
|
|
|
|
|
374,710
|
|
|
|
377,908
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares, authorized 1,000,000,000 shares at par value $0.001, issued and outstanding as of September 30, 2021 – 515,468,779 and December 31, 2020 – 464,817,339 shares.
|
|
|
|
|
515,468
|
|
|
|
464,817
|
|
Additional paid in capital
|
|
|
|
|
17,841,513
|
|
|
|
16,321,969
|
|
Accumulated comprehensive income
|
|
|
|
|
131,859
|
|
|
|
131,859
|
|
Deficit
|
|
|
|
|
(18,686,550
|
)
|
|
|
(17,120,553
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Total Shareholders' Equity
|
|
|
|
|
(197,710
|
)
|
|
|
(201,908
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
|
|
$
|
177,000
|
|
|
$
|
176,000
|
|
The
Accompanying notes are integral part of these unaudited financial statements.
Earth
Life Sciences Inc.
|
Statement
of Operations
Unaudited
|
|
|
Three months ended
September 30, 2021
|
|
|
Three months
ended
September 30,
2020
|
|
|
Nine months ended
September 30, 2021
|
|
|
Nine months ended
September 30,
2020
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consulting and subcontractors
|
|
$
|
7,500
|
|
|
$
|
4,500
|
|
|
$
|
14,760
|
|
|
$
|
4,500
|
|
Interest
|
|
|
5,654
|
|
|
|
-
|
|
|
|
16,233
|
|
|
|
|
|
Office and general
|
|
|
9,252
|
|
|
|
5,180
|
|
|
|
15,460
|
|
|
|
30,404
|
|
Stock-based compensation
|
|
|
-
|
|
|
|
-
|
|
|
|
1,519,544
|
|
|
|
1,787,500
|
|
Total Expenses
|
|
|
22,406
|
|
|
|
9,680
|
|
|
|
1,565,997
|
|
|
|
1,822,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss for the period
|
|
|
(22,406
|
)
|
|
|
(9,680
|
)
|
|
|
(1,565,997
|
)
|
|
|
(1,822,404
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss)
|
|
$
|
(22,406
|
)
|
|
$
|
(9,680
|
)
|
|
$
|
(1,565,997
|
)
|
|
$
|
(1,822,404
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share, basic and diluted
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding
|
|
|
501,688,608
|
|
|
|
438,474,798
|
|
|
|
501,688,608
|
|
|
|
438,474,798
|
|
The
Accompanying notes are integral part of these unaudited financial statements.
Earth Life Sciences Inc.
|
Statements
of Cash Flows
|
(unaudited)
|
|
|
Nine months ended
September 30, 2021
|
|
|
Nine months
ended September 30,
2020
|
|
Cash Flows from Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss for the period
|
|
$
|
(1,565,997
|
)
|
|
$
|
(1,822,404
|
)
|
Items not affecting cash:
|
|
|
|
|
|
|
|
|
Accrued interest
|
|
|
16,233
|
|
|
|
-
|
|
Stock-based compensation
|
|
|
1,519,544
|
|
|
|
1,787,500
|
|
|
|
|
(30,220
|
)
|
|
|
(34,904
|
)
|
Changes in non-cash working capital:
|
|
|
|
|
|
|
|
|
Prepaid expenses
|
|
|
(1,000
|
)
|
|
|
-
|
|
Related parties
|
|
|
(665
|
)
|
|
|
(7,407
|
)
|
Accounts payable and accrued liabilities
|
|
|
16,017
|
|
|
|
14,599
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
(15,868
|
)
|
|
|
(24,712
|
)
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities
|
|
|
|
|
|
|
|
|
Advances received from a shareholder
|
|
|
15,868
|
|
|
|
24,712
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
15,868
|
|
|
|
24,712
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
-
|
|
|
|
-
|
|
Cash and cash equivalents at beginning of period
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
-
|
|
|
$
|
-
|
|
Income taxes paid
|
|
$
|
-
|
|
|
$
|
-
|
|
Shares issued in trust
|
|
$
|
-
|
|
|
$
|
1,787,500
|
|
Shares issued for software technology
|
|
$
|
-
|
|
|
$
|
176,000
|
|
Shares returned to treasury and cancelled
|
|
$
|
-
|
|
|
$
|
-
|
|
The
Accompanying notes are integral part of these unaudited financial statements.
Earth
Life Sciences Inc.
|
Statements
of Changes in Shareholders Equity
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Capital
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Additional
paid-in
capital
|
|
|
Deficit
|
|
|
Cumulative
other
comprehensive
income
|
|
|
Total
|
|
Balance, January 1, 2020
|
|
|
332,817,339
|
|
|
$
|
332,817
|
|
|
$
|
14,490,469
|
|
|
$
|
(15,292,929
|
)
|
|
$
|
131,859
|
|
|
$
|
(337,784
|
)
|
Share cancellations
|
|
|
(225,000,000
|
)
|
|
|
(225,000
|
)
|
|
|
225,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Issued for technology acquisition
|
|
|
32,000,000
|
|
|
|
32,000
|
|
|
|
144,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
176,000
|
|
Shares issued in trust
|
|
|
325,000,000
|
|
|
|
325,000
|
|
|
|
1,462,500
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,787,500
|
|
Loss for the period
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,822,404
|
)
|
|
|
-
|
|
|
|
(1,822,404
|
)
|
Balance, September 30, 2020
|
|
|
464,817,339
|
|
|
$
|
464,817
|
|
|
$
|
16,321,969
|
|
|
$
|
(17,115,333
|
)
|
|
$
|
131,859
|
|
|
|
(196,688
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2021
|
|
|
464,817,339
|
|
|
|
464,817
|
|
|
|
16,321,969
|
|
|
|
(17,120,553
|
)
|
|
|
131,859
|
|
|
|
(201,908
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued for debt
|
|
|
50,651,440
|
|
|
|
50,651
|
|
|
|
1,519,544
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,519,544
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss for the period
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,565,997
|
)
|
|
|
-
|
|
|
|
(1,565,997
|
)
|
Balance, September 30, 2021
|
|
|
515,468,779
|
|
|
$
|
515,468
|
|
|
$
|
17,841,513
|
|
|
$
|
(18,686,550
|
)
|
|
$
|
131,859
|
|
|
$
|
(197,710
|
)
|
The
Accompanying notes are integral part of these unaudited financial statements.
EARTH LIFE SCIENCES INC.
|
(A Development Stage Company)
|
|
NOTES TO THE FINANCIAL STATEMENTS
|
September 30, 2021
|
NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS
Earth Life Sciences Inc. (the Company)
was incorporated in the state of Nevada on November 2, 2001. Originally the corporate name was Altus Explorations, Inc. On June
2, 2014, the Company changed its name to Earth Life Sciences Inc.
On October 1, 2010, the Company entered
into a Share Exchange Agreement (the Agreement) with UWD Unitas World Development Inc. (UWD), a privately
held Canadian incorporated company. Pursuant to the Agreement, the Company issued 80,000,000 shares of common stock for the acquisition
100% of the issued shares of Canadian Tactical Training Academy Inc (CTTA). The Company operations consisted of the
training of law enforcement, security, investigation and protection for officers and individuals. During the year ended December
31, 2015 the Company discontinued the operations of CTTA and returned the shares of CTTA.
On June 12, 2015, the Company, through
an option agreement, issued 225,000,000 shares to Mr. Song Bo, to earn the mineral rights for the White Channel mineral claims
located in British Columbia. The Company embarked on mineral exploration program. During the year ended December 31, 2017 the Company
terminated the exploration and development of the White Channel property based on unfavorable economics of the mineral resources.
The Company returned 225,000,000 shares held in trust to the Company treasury in 2020.
The Company has entered into the transportation
software market (Note 3).
These financial statements have been prepared
on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal
course of business. The Company is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future.
The continuation of the Company as a going concern and the ability of the Company to emerge from the Development stage are dependent
upon managements successful efforts to raise additional equity financing to continue operations and generate sustainable
significant revenues.
These financial statements do not include
any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might
be necessary should the Company be unable to continue as a going concern. The Company will require significant additional financial
resources and will be dependent on future financings to fund its ongoing operations as well as other working capital requirements.
There is no guarantee that management will be able to raise adequate equity financings or generate profits from operations. These
factors raise substantial doubt regarding the Companys ability to continue as a going concern.
Management of the Company has undertaken
steps as part of a plan with the goal of sustaining Company operations for the next twelve months and beyond. These steps include:
(a) continuing efforts to raise additional capital and/or other forms of financing; and (b) controlling overhead and expenses.
Management is aware that material uncertainties exist, related to current economic conditions, which could cast a doubt about the
Companys ability to continue to finance its activities. It is to be expected that the Company may incur further losses in
the Development of its business and there can be no assurance that any of these efforts will be successful.
NOTE 2 - SUMMARY OF ACCOUNTING POLICIES
Basis of Presentation
The financial statements of the Company
have been prepared in accordance with accounting principles generally accepted in the United States of America (US GAAP)
and are expressed in U.S. dollars. The Companys fiscal year-end is December 31.
Use of Estimates
The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts
of revenues and expenses during the reporting periods. Actual results could materially differ from those estimates and assumptions.
Significant areas requiring the use of management estimates relate to the determination of impairment of long-lived assets, expected
tax rates for future income tax recoveries and determining the fair values of financial instruments.
Equipment
Equipment is recorded at cost. Additions
are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are
reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets.
Impairment of Assets
The Company reviews the carrying value
of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical carrying value of
an asset may no longer be appropriate. The Company assesses recoverability of the carrying value cost of the asset by estimating
the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less
than the carrying value of the asset, an impairment loss is recorded equal to the difference between the assets carrying
value and fair value.
Other Comprehensive Income
The Company reports and displays comprehensive
income and its components in the financial statements. During the periods ended September 30, 2021 and 2020, the Company recorded
unrealized foreign exchange gains of $nil and $nil respectfully.
Income Taxes
The Company uses the asset and liability
method of accounting for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future
tax consequences attributable to temporary differences between the financial statements carrying amounts of assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled.
The Company recognizes the financial statement
benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position
following an audit. For tax positions meeting this standard, the amount recognized in the financial statements is the largest benefit
that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.
Basic and Diluted Loss per Share
Basic loss per share is computed using
the weighted average number of common shares outstanding during the year. Diluted earnings per share reflect the potential dilution
that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options
and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities
by the if converted method. For the years presented, diluted loss per share is equal to basic loss per share as the
effect of the computations are anti-dilutive.
Financial Instruments
The Companys balance sheet includes
financial instruments, specifically accounts payable, accrued expenses, and payables to related parties. The carrying amounts of
current assets and current liabilities approximate their fair value because of the relatively short period of time between the
origination of these instruments and their expected realization.
ASC 820, Fair Value Measurements and
Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an
exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants
on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant
assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entitys
own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable
inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices
in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three
levels of the fair value hierarchy are described below:
Level 1 - Unadjusted quoted prices
in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities
Level 2 - Inputs other than quoted
prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted
prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets
that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and
inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 - Inputs that are both
significant to the fair value measurement and unobservable.
Fair value estimates discussed herein are
based upon certain market assumptions and pertinent information available to management as of September 30, 2020. The respective
carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of
these instruments.
Revenue Recognition
The Company follows ASC 605, Revenue Recognition
-The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable
and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been
shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability
is reasonably assured. The Company provides services to companies on a time and materials basis and recognizes revenues upon billing
of time and materials at which all services have been completed and there is no warranty or returns on services.
Deferred Income Taxes and Valuation
Analysis
The Company accounts for income taxes under
ASC 740 Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets
and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect
on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation
allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets
through future operations. No deferred tax assets or liabilities were recognized as of September 30, 2021 or December 31, 2020.
Net Income (loss) per Common Share
Net income (loss) per share is calculated
in accordance with ASC 260, Earnings Per Share. The weighted-average number of common shares outstanding during each
period is used to compute basic earning or loss per share. Diluted earnings or loss per share is computed using the weighted average
number of shares and diluted potential common shares outstanding. Dilutive potential common shares are additional common shares
assumed to be exercised.
Basic net income (loss) per common share
is based on the weighted average number of shares of common stock outstanding at September 30, 2021 and 2020.
Share Based Compensation
ASC 718, Compensation – Stock
Compensation, prescribes accounting and reporting standards for all share-based payment transactions in which employee services
are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments
such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee
stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized
over the period during which an employee is required to provide services in exchange for the award, known as the requisite service
period (usually the vesting period).
The Company accounts for stock-based compensation
issued to non-employees and consultants in accordance with the provisions of ASC 505-50, Equity – Based Payments to Non-Employees.
Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable:
(a) the goods or services received; or (b) the equity instruments issued.
Share-based expense for the periods ended
September 30 2021 and 2020 totaled $1,519,544 and $1,787,500 and $nil, respectively.
NOTE 3 – SOFTWARE TECHNOLOGY
The Company entered into an agreement with
the Software Group in January of 2020. The Company issued 32,000,000 restricted common shares to the four members of the Software
Group as general consideration. The Company also issued 325 million common shares to an escrow agent. Pursuant to the terms of
the agreement the escrow agent will transfer 125 million shares to the Software Group upon the Company receiving a working version
of the software and necessary support documentation, after testing, acceptance, and license transfer of the software. Further transfer
of 100 million shares held by the escrow agent will be based on gross sales of $1 million being reached in a consecutive twelve-month
period within 3 years, and a further 100 million shares after gross sales of $5 million being reached in a consecutive twelve-month
period within 5 years. All shares issued were restricted.
NOTE 4 – CONVERTIBLE NOTE PAYABLE
As of September 30, 2021, the Company
had convertible notes payable totaling $260,753 (December 31, 2020 - $297,603). Convertible notes were issued on July 1, 2020 pursuant
to the conversion of Notes Payable of $264,883 as of June 30, 2020 (Amounts payable December 31, 2019 of $248,103). Previously
convertible notes payable consisted of the conversion of a Notes Payable in 2011 and had no interest rate and no fixed terms of
repayment. The recent convertible notes payable have an interest rate of 8% commencing on January 1, 2021. All of the notes are
convertible into common shares at $0.001 per share. Currently, the notes could be converted to 260,753,000 shares.
NOTE 5 – COMMON STOCK
As of September 30, 2021, the Company had
1,000,000,000 shares of $0.001 par value common shares authorized. On October 8, 2020, the authorized share capital was increased
from 500,000,000 shares to 1,000,000,000 common shares.
NOTE 6 – INCOME TAXES
The Company is subject to United States
federal and state income taxes at an approximate rate of 27%. The amount taken into income as deferred income tax assets must reflect
that portion of the income tax loss carry forwards that is more likely-than-not to be realized from future operations. The Company
has chosen to provide a full valuation allowance against all available income tax loss carry forwards, regardless of their time
of expiry.
No provision for income taxes has been
provided in these financial statements due to the net loss for the years ended December 31, 2020 and 2019. The potential tax benefit
of these losses may be limited due to certain change in ownership provisions under Section 382 of the Internal Revenue Code and
similar state provisions.
NOTE 7 – NOTES PAYABLE
As of September 30, 2021 the Company had
notes payable of $46,903 (December 31, 2020 - $28,603). The notes are repayable to arms-length lenders for advances received by
the Company starting in 2015. On June 30, 2020, the Company agreed to pay interest at the rate of 8% per annum starting on January
1, 2021. The notes payable are payable on demand. On July 1, 2020 Notes Payable of $264,883 were changed to convertible .notes
payable. See Note 4.